Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3101
Imunon
IMNN
$6.06M
| $168K | ﹤0.01% |
50
+31
| +163% | +$106K |
2015 Q4
3 quarters
|
|
3102
Universal Safety Products Inc
UUU
$15.7M
| $168K | ﹤0.01% |
44,200
+700
| +2% | +$2.29K |
2014 Q4
7 quarters
|
|
3103
Ocean Power Technologies
OPTT
$7.63M
| $167K | ﹤0.01% |
39
-56
| -59% | -$256K |
2014 Q4
7 quarters
|
|
|
ALDW
3104
DELISTED
Alon USA Partners LP
ALDW
| $165K | ﹤0.01% |
+19,200
| New | +$188K |
2016 Q3
0 quarters
|
|
|
RTC
3105
DELISTED
Baijiayun Group
RTC
| $164K | ﹤0.01% |
16,135
+250
| +2% | +$3.62K |
2013 Q2
13 quarters
|
|
|
CELP
3106
DELISTED
Cypress Environmental Partners, L.P.
CELP
| $163K | ﹤0.01% |
+16,700
| New | +$159K |
2016 Q3
0 quarters
|
|
|
AMRN
3107
Amarin Corp
AMRN
$254M
| $161K | ﹤0.01% |
+2,530
| New | +$142K |
2016 Q3
0 quarters
|
|
3108
InspireMD
NSPR
$24.4M
| $158K | ﹤0.01% |
+3
| New | +$311K |
2015 Q1
6 quarters
|
|
|
SHLO
3109
DELISTED
Shiloh Industries Inc
SHLO
| $158K | ﹤0.01% |
+22,300
| New | +$184K |
2016 Q3
0 quarters
|
|
3110
Iovance Biotherapeutics
IOVA
$6.62B
| $156K | ﹤0.01% |
+19,000
| New | +$161K |
2016 Q3
0 quarters
|
|
|
UNAM
3111
DELISTED
Unico American Corp
UNAM
| $156K | ﹤0.01% |
14,100
| – | – |
2014 Q4
7 quarters
|
|
|
NSAT
3112
DELISTED
Norsat International Inc.
NSAT
| $156K | ﹤0.01% |
+19,500
| New | +$128K |
2016 Q3
0 quarters
|
|
3113
Indaptus Therapeutics
INDP
$334M
| $154K | ﹤0.01% |
+12
| New | +$149K |
2016 Q3
0 quarters
|
|
3114
Savara
SVRA
$1.01B
| $154K | ﹤0.01% |
19,951
+8,077
| +68% | +$229K |
2016 Q1
2 quarters
|
|
3115
Kura Oncology
KURA
$943M
| $153K | ﹤0.01% |
24,400
+11,100
| +83% | +$56.2K |
2016 Q2
1 quarter
|
|
3116
Atlantic American Corp
AAME
$24.1M
| $152K | ﹤0.01% |
47,000
+500
| +1% | +$1.85K |
2013 Q2
13 quarters
|
|
3117
Mega Matrix
MPU
$9.35M
| $152K | ﹤0.01% |
4,075
+125
| +3% | +$4.5K |
2013 Q2
13 quarters
|
|
|
MOBI
3118
DELISTED
Sky-mobi Limited ADS
MOBI
| $152K | ﹤0.01% |
+74,901
| New | +$147K |
2016 Q3
0 quarters
|
|
3119
Citizens Community Bancorp
CZWI
$204M
| $151K | ﹤0.01% |
+13,500
| New | +$142K |
2016 Q3
0 quarters
|
|
|
EIGI
3120
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $151K | ﹤0.01% |
+17,300
| New | +$144K |
2016 Q3
0 quarters
|
|
|
ESMC
3121
DELISTED
Escalon Medical Corp
ESMC
| $151K | ﹤0.01% |
225,900
+3,300
| +1% | +$2.38K |
2013 Q2
13 quarters
|
|
|
SDEV
3122
Stablecoin Development Corp
SDEV
$77.9M
| $149K | ﹤0.01% |
6
| – | – |
2014 Q2
9 quarters
|
|
|
PERF
3123
DELISTED
Perfumania Holdings, Inc.
PERF
| $149K | ﹤0.01% |
68,239
+100
| +0.1% | +$228 |
2013 Q2
13 quarters
|
|
|
ELP
3124
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $148K | ﹤0.01% |
35,750
-403,250
| -92% | -$1.64M |
2016 Q1
2 quarters
|
|
3125
Eterna Therapeutics
ERNA
$2.8M
| $148K | ﹤0.01% |
1
| – | – |
2013 Q2
13 quarters
|
|
Similar funds
Renaissance Technologies's Q3 2016 Portfolio in Review
As of Q3 2016, Renaissance Technologies held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $1.92B of net new capital in Q3 2016, opening 413 new positions and adding to 1,833 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Renaissance Technologies's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Renaissance Technologies's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Renaissance Technologies fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Renaissance Technologies opened 413 new positions and closed 416 in Q3 2016.
- Renaissance Technologies's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.